← Back to Patent Explorer
US4331697A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative

Assignee: Teijin Ltd
•
Filing: 1980-09-02
•
Granted: 1982-05-25
•
Expires: 2000-09-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A heparin derivative in which at least 0.5% of the entire hydroxyl groups of heparin are in the form of an ester of the following formula ##STR1## wherein R 1 , R 2 and R 3 each represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; a method for producing aforesaid heparin derivative which comprises reacting heparin with a halide or anhydride of an unsaturated carboxylic acid of the formula ##STR2## wherein R 1 , R 2 and R 3 are the same as defined above; and a method for imparting antithrombotic activity to a biomedical material, which comprises treating that surface of the biomedical material which makes contact with the blood with actinic light in the presence of aforesaid heparin derivative.

Inventors

  • 👤 Akira Kudo
  • 👤 Hiroo Inata
  • 👤 Makoto Ogasawara

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 20:59
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; A; A61; A61L; A61L33/00; A61L33/0005; A61L33/0011

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 83 words
A method for imparting antithrombotic activity to a biomedical material, which comprises treating that surface of the biomedical material which makes contact with the blood with actinic light in the presence of a heparin derivative in which at least 0.5% of the entire hydroxyl groups of heparin are in the form of an ester of the following formula ##STR8## wherein R 1 , R 2 and R 3 each represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.
Claim 2
Independent Claim 83 words
A method for imparting antithrombotic activity to a biomedical material, which comprises treating that surface of the biomedical material which makes contact with the blood with actinic light in the presence of a heparin derivative in which at least 0.5% of the entire hydroxyl groups of heparin are in the form of an ester of the following formula ##STR8## wherein R 1 , R 2 and R 3 each represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.
Claim 3
Dependent Claim 18 words
The method of claim 1 wherein at least the surface of said biomedical material is a hydrophilic substance.
Claim 4
Independent Claim 67 words
A method for imparting antithrombotic activity to a biomedical material, which comprises forming at least that surface of the biomedical material which makes contact with the blood from a polymer having a carboxylic acid halide group and/or a carboxylic anhydride group in the side chain, and treating said surface with a solution of heparin wherein at least 0.5% of the entire hydroxyl groups of heparin are esterified.
Claim 5
Independent Claim 67 words
A method for imparting antithrombotic activity to a biomedical material, which comprises forming at least that surface of the biomedical material which makes contact with the blood from a polymer having a carboxylic acid halide group and/or a carboxylic anhydride group in the side chain, and treating said surface with a solution of heparin wherein at least 0.5% of the entire hydroxyl groups of heparin are esterified.
Claim 6
Dependent Claim 26 words
The method of claim 1 wherein both R 1 and R 2 are hydrogen atoms and R 3 is a hydrogen atom or a methyl group.
Claim 7
Dependent Claim 23 words
The method of claim 1 wherein the treatment with actinic light is conducted at a temperature of from -10° C. to 70° C.

References Cited (Backward Citations)

US3211617A Cited
US3835112A Cited
US3844989A Cited
JPS4938945A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-24 1985-11-23 1986-05-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-24 1989-11-23 1990-05-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-24 1993-11-23 1994-05-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag